Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

BBC Africa Eye and Anas Aremeyaw Anas expose Covid-19 scam

researchsnappy by researchsnappy
October 5, 2020
in Healthcare Research
0
401
SHARES
2.4k
VIEWS
Share on FacebookShare on Twitter

An underworld of quack doctors have been exploiting the coronavirus pandemic and making money selling fake coronavirus cures. BBC Africa Eye reports. Investigative reporter Anas Aremeyaw Anas goes undercover in Ghana, exposing a Covid-19 scam said to be worth tens of thousands of dollars.

Anas Aremeyaw Anas

WHO estimates 100 000 people die as a consequence of fake medicines every year in Africa. Posing as the brother of a man infected with the deadly coronavirus, Anas sets out to find so-called cures, to expose the men who sell them, and to test the liquids for potentially dangerous and toxic ingredients.

The investigation focuses on two case studies: the so-called ‘Abdellah brothers’ and COA FS.

The Abdellah brothers

Dr Abdellah Jr and Dr Abdellah Sr are the masterminds of a Covid-19 scam said to be worth tens of thousands of dollars.

  • During lockdown, they produced hundreds of bottles of a product labelled “Covid Cure.” It has a fake FDA number on its label. 
  • They claimed people took their children out of hospital quarantine to take their drug.  They also claimed to be actively treating a number of coronavirus patients.
  • They attempted to sell our undercover team 100 bottles of their concoction for 150 000 cedis [almost $26,000 USD].
  • We tested their concoction with the Ghana Standards Authority. It failed to meet the standards for human consumption and was contaminated with bacteria, mould and traces of phosphine. These can all be dangerous depending on the dosage.

The two men are currently being questioned by the FDA.

When we sent them our allegations they told the BBC they are in the process of licencing their product and that it is for testing purposes only. They denied selling it to anybody.

COA FS

COA FS is registered as a food supplement, licenced for general welfare. There is no regulatory basis for it to be marketed as a cure or a treatment for any disease in Ghana. Despite this, the creator of the product, Samuel Ato Duncan, has repeatedly claimed it can treat various diseases.

After initially announcing COA FS is a “potential cure for coronavirus” in March 2020, Duncan reversed his stance on 15 March – issuing a statement claiming the product “is not a cure for coronavirus.”

The investigation found that a COA FS agent, Kafui Alornu, continued to market the drug as a cure for the virus after this disclaimer.

On 16 April 2020, he sold a bottle of COA FS to our undercover reporters and told them it can “heal” and “cure” coronavirus patients. He gave us instructions on how to administer the product for this purpose.

We tested two samples of COA FS which we bought with the Ghana Standards Authority, which is ISO certified and one of the best laboratories in the country. The samples failed to meet the standards for human consumption. They were found to be contaminated with quantities of mould which were “too numerous to be counted”.

There were also traces of phosphine in the product. Depending on how much is consumed, these contaminants have the potential to cause ill health.

The test results, on two samples, are not definitive. Further tests will be needed to assess the safety of the product. 

We contacted COA drugs and Duncan but they did not provide a substantive response to the allegations.

Watch the full video below:

//youtu.be/qX0jbLxFQ90

Want to continue this conversation on The Media Online platforms? Comment on Twitter @MediaTMO or on our Facebook page. Send us your suggestions, comments, contributions or tip-offs via e-mail to [email protected].

Previous Post

NESG v CBN: Issues Deconstructed: In Praise of Contexts

Next Post

Amundi becomes Fund Channel’s sole shareholder and reaffirms its ambitions for the platform Paris Stock Exchange:AMUN

Next Post
Amundi becomes Fund Channel’s sole shareholder and reaffirms its ambitions for the platform Paris Stock Exchange:AMUN

Amundi becomes Fund Channel's sole shareholder and reaffirms its ambitions for the platform Paris Stock Exchange:AMUN

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com